Browse Prostate cancer topic

Conferences, meetings and seminars subtopic

Articles

1-27 out of 27 article(s)

Title	Type	Date	Words
Global Prostate Cancer Research Meeting Opens.		Sep 24, 2009	530
Cougar Biotechnology Presents Positive CB7630 (Abiraterone Acetate) Phase II Data at ASCO Annual Meeting.		May 31, 2009	1426
Calypso[R] Medical Exhibits at American Urological Association Annual Meeting.		Apr 23, 2009	625
Cougar Biotechnology Announces Presentation of Positive CB7630 (Abiraterone Acetate) Phase II Data at ASCO 2009 Genitourinary Cancers Symposium.	Clinical report	Feb 27, 2009	1333
Cougar Biotechnology Presents Positive CB7630 Phase II Data at EORTC-NCI-AACR Symposium.		Oct 23, 2008	827
New Prostate Cancer Test to be Presented at Biomarker Discovery Europe 2008 Conference.	Conference news	Aug 11, 2008	627
IsoRay Conducts Second Proxcelan Cs-131 Workshop at Chicago Prostate Cancer Center in 2008.		Jun 12, 2008	766
Cougar Biotechnology Presents Positive CB7630 (Abiraterone Acetate) Phase I and Phase II Data at ASCO 2008 Annual Meeting.		Jun 2, 2008	2516
Cougar Biotechnology Announces Presentation of Positive CB7630 Phase I Clinical Data at ASCO 2008 Genitourinary Cancers Symposium.		Feb 15, 2008	835
Cougar Biotechnology Presents Positive CB7630 Phase I and Phase II Data at ASCO 2008 Genitourinary Cancers Symposium.		Feb 14, 2008	1998
IsoRay Conducts Proxcelan Cs-131 Workshop at Chicago Prostate Cancer Center.		Feb 7, 2008	694
Cougar Biotechnology Presents Positive CB7630 Phase II Data at Chemotherapy Foundation Symposium.		Nov 9, 2007	852
Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics.	Conference news	Oct 25, 2007	832
Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at ESMO Conference.		Jul 8, 2007	1435
Major Milestones Announced for Sonablate 500 HIFU Treatment of Prostate Cancer at Annual American Urology Association Conference.		Jun 6, 2007	1537
Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at ASCO Annual Meeting.		Jun 4, 2007	1553
Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at AUA Annual Meeting.		May 21, 2007	995
Cougar Biotechnology Presents Positive CB7630 Clinical Data at AACR Annual Meeting Late-Breaking Clinical Trials Session.		Apr 17, 2007	1233
New Clinical Data for PROSTASCINT(R) and QUADRAMET(R) in Prostate Cancer Presented at the 2007 Prostate Cancer Symposium.		Feb 24, 2007	2617
Cougar Biotechnology Announces Presentation of Positive Phase I and Phase II Data at ASCO Prostate Cancer Symposium.		Feb 23, 2007	1369
GTx Announces Presentation of ACAPODENE Data At ASCO Prostate Cancer Symposium.		Feb 21, 2007	768
Cougar Biotechnology Presents Positive CB7630 Phase I data at the AACR Innovations in Prostate Cancer Research Conference.		Dec 8, 2006	719
Cougar Biotechnology Announces Positive CB7630 Phase I data Presented at the National Cancer Research Institute Conference.		Oct 9, 2006	765
Cougar Biotechnology Announces CB7630 Phase I Data to Be Presented at National Cancer Research Institute Conference.		Sep 27, 2006	573
Geron Corporation Announces Multiple Presentations on Telomerase at the AACR 2006 Annual Meeting.		Apr 6, 2006	1355
Somanta Presents Positive Data from Alchemix on Multiple Cancer Cell Lines at Prostate Cancer Update Conference.		Jan 18, 2006	660
ASTRO Annual Meeting Thru Wednesday (Colorado Convention Center); IsoRay Medical's New Cesium-131 Radioactive Isotope Seed Offers Aggressive Option for Treatment of Prostate Cancer; FDA Approved for Other Malignant Cancers.		Oct 17, 2005	610